Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Inform Genomics Inc.

Predicting side effects of specific drug regimens

This article was originally published in Start Up

Executive Summary

While other personalized medicine companies tend to focus on selecting the most effective therapeutic drug, say for cancer, Inform Genomics Inc.’s focus with its lead product is to identify patients who have a genetic predisposition to specific side effects from cancer treatments. The company is looking across vast networks of genes to pinpoint characteristics that spell trouble for a patient. Each genetic profile is unique to the risks associated with a specific drug regimen: a patient’s profile may raise a red flag for severe side effects associated with one regimen, but may show that another regimen may be relatively safe.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC092360

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel